NLRP3 and lung cancer: Mechanistically, the downregulation of miR-556-5p contributes to the expression of NLRP3, thereby provoking pyroptosis in cisplatin-treated CR-NSCLC cells.137 NLRP3-independent pyroptotic pathways influence the onset and progression of lung cancer.